Surface Plasmon Resonance Market size is predicted to be valued at US$ 1807.7 million by 2032 | FMI
The Surface Plasmon Resonance Market is expected to grow from US$910.4 million in 2022 to US$1807.7 million in 2032. According to FMI, the market is expected to grow at a CAGR of 7.1% during the forecast period.
Increasing adoption of label-free detection techniques over labelled detection techniques is due to their cost-effective nature. Additionally, the availability of versatile products coupled with surface plasmon resonance to enhance the specificity of tests is an important factor that will bolster the demand for surface plasmon resonance.
Imaging systems help in increasing throughput at a remarkable speed and with precise motion and consistency in report generation. Furthermore, the introduction of multifunctional products for improved outcomes is also expected to drive the growth of the surface plasmon resonance market over the forecast period.
Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-962
Key Takeaways of Surface Plasmon Resonance Market Study
- The market share of imaging systems is evaluated to grow at a significant rate by the end of 2029, as these are the ideal solution for the analysis of label-free and multiplexed biomolecules.
- Sales of surface plasmon resonance (spr) biosensors are envisaged to be higher in North America. Increasing adoption of imaging systems and biosensors in life science R&D is anticipated to boost the growth of the surface plasmon resonance market in the region.
- Innovation while developing imaging software used in surface plasmon resonance for the analysis of kinetic parameters of biomolecular interactions is a key aspect for increasing the reproducibility of results. Companies are investing in R&D initiatives to introduce superior imaging devices with enhanced magnification, to observe the smallest deflection in the refractive index, thus aiding the growth of the surface plasmon resonance market.
“Increasing application of surface plasmon resonance in the field of drug discovery and medical imaging is contributing to the growth of the surface plasmon resonance market. Development of new technologies coupled with surface plasmon resonance, such as nanoparticle surface plasmon resonance and microfluidics, is playing an important role in the overall growth of the global surface plasmon resonance market.”
Have a Conversation with the Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-962
Adoption of Label-free Detection Technique for Analysis of Biomolecules
Detection of biological analytes through their physical properties is difficult. As a result, researchers rely on the addition of some sort of label to one or more of the analytes that need to be studied. Inclusion of this label for increasing specificity and accuracy has increased the cost of reagents and assays.
To reduce assay cost and complexity while providing more qualitative information through labelled detection, adoption of the label-free detection technique such as surface plasmon resonance has increased, and is expected to fuel the growth of the global surface plasmon resonance market during the forecast period. The label-free detection technique simplifies the procedure by reducing the time and effort required for the development of the assay. Thus, increasing adoption of label-free detection techniques over labelled detection is expected to boost the growth of the global surface plasmon resonance market.
Surface plasmon resonance (SPR) is a powerful analytical technique that is used to study molecular interactions in real-time. It is based on the phenomenon of surface plasmons, which are collective oscillations of electrons on the surface of a metal.
Key players:
- GE Healthcare
- AMETEK.Inc.
- Horiba
Use promo code ->> FMITODAY to get a flat 20% discount
Key Segments
By Product:
- Imaging System
- Sensor System
- Reagents
By Application:
- Drug Discovery
- Material Science
- Biosensors
By End User:
- Academic & Research Institutes
- Food & Beverage Industry
- Biopharmaceutical Companies
- CROs
- Others
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
Editor Details
-
Company:
- MARKITWIRED
- Website: